209 related articles for article (PubMed ID: 31455580)
21. In vitro activities of carvacrol, cinnamaldehyde and thymol against Candida biofilms.
Miranda-Cadena K; Marcos-Arias C; Mateo E; Aguirre-Urizar JM; Quindós G; Eraso E
Biomed Pharmacother; 2021 Nov; 143():112218. PubMed ID: 34649348
[TBL] [Abstract][Full Text] [Related]
22. Azole and terbinafine susceptibility testing of Malassezia pachydermatis in Japan.
Murayama N; Kano R
J Vet Med Sci; 2023 Mar; 85(3):383-385. PubMed ID: 36724970
[TBL] [Abstract][Full Text] [Related]
23. Subculture on potato dextrose agar as a complement to the broth microdilution assay for Malassezia pachydermatis.
Prado MR; Brito EH; Brilhante RS; Cordeiro RA; Leite JJ; Sidrim JJ; Rocha MF
J Microbiol Methods; 2008 Oct; 75(2):341-3. PubMed ID: 18603321
[TBL] [Abstract][Full Text] [Related]
24. Oxythiamine improves antifungal activity of ketoconazole evaluated in canine Malassezia pachydermatis strains.
Siemieniuk M; Sosnowska K; Czerniecki J; Czyzewska U; Winnicka K; Tylicki A
Vet Dermatol; 2018 Dec; 29(6):476-e160. PubMed ID: 30251451
[TBL] [Abstract][Full Text] [Related]
25. Assessment of the antifungal susceptibility of Malassezia pachydermatis in various media using a CLSI protocol.
Cafarchia C; Figueredo LA; Favuzzi V; Surico MR; Colao V; Iatta R; Montagna MT; Otranto D
Vet Microbiol; 2012 Oct; 159(3-4):536-40. PubMed ID: 22622336
[TBL] [Abstract][Full Text] [Related]
26. Assessment of in vitro inhibitory activity of hydrogen peroxide on the growth of Malassezia pachydermatis and to compare its efficacy with commercial ear cleaners.
Marrero EJ; Silva FA; Rosario I; Déniz S; Real F; Padilla D; Díaz EL; Acosta-Hernández B
Mycoses; 2017 Oct; 60(10):645-650. PubMed ID: 28557001
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of manuka honey with conventional antifungals on
Váczi P; Čonková E; Malinovská Z
Pol J Vet Sci; 2023 Jun; 26(2):257-263. PubMed ID: 37389413
[TBL] [Abstract][Full Text] [Related]
28. Genomic Tandem Quadruplication is Associated with Ketoconazole Resistance in
Kim M; Cho YJ; Park M; Choi Y; Hwang SY; Jung WH
J Microbiol Biotechnol; 2018 Nov; 28(11):1937-1945. PubMed ID: 30562885
[No Abstract] [Full Text] [Related]
29. In vitro activity of five antifungal agents against Malassezia pachydermatis.
Uchida Y; Nakade T; Kitazawa K
Nihon Juigaku Zasshi; 1990 Aug; 52(4):851-3. PubMed ID: 2391785
[No Abstract] [Full Text] [Related]
30. Sequential exposure of Malassezia pachydermatis to azoles: enhanced or decreased activity?
Schlemmer KB; Jesus FP; Zanette RA; Zimmermann CE; Lautert C; Alves SH; Santurio JM
Vet Microbiol; 2014 Jun; 171(1-2):255-6. PubMed ID: 24786225
[No Abstract] [Full Text] [Related]
31. [Antibacterial activity of thymol, carvacrol and cinnamaldehyde alone or in combination].
Didry N; Dubreuil L; Pinkas M
Pharmazie; 1993 Apr; 48(4):301-4. PubMed ID: 8321882
[TBL] [Abstract][Full Text] [Related]
32. In vitro sensitivity of Malassezia spp. to various antimycotics.
Lorenzini R; Mercantini R; De Bernardis F
Drugs Exp Clin Res; 1985; 11(6):393-5. PubMed ID: 3836136
[TBL] [Abstract][Full Text] [Related]
33. In vitro effects of omeprazole in combination with antifungal compounds against Malassezia pachydermatis.
Shin J; Bae S
Vet Med Sci; 2023 Nov; 9(6):2594-2599. PubMed ID: 37872836
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of medicinal essential oils against pathogenic Malassezia sp. isolates.
Khosravi AR; Shokri H; Fahimirad S
J Mycol Med; 2016 Mar; 26(1):28-34. PubMed ID: 26597143
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo activity of a killer peptide against Malassezia pachydermatis causing otitis in dogs.
Cafarchia C; Immediato D; Paola GD; Magliani W; Ciociola T; Conti S; Otranto D; Polonelli L
Med Mycol; 2014 May; 52(4):350-5. PubMed ID: 24625672
[TBL] [Abstract][Full Text] [Related]
36. An azole-resistant isolate of Malassezia pachydermatis.
Nijima M; Kano R; Nagata M; Hasegawa A; Kamata H
Vet Microbiol; 2011 Apr; 149(1-2):288-90. PubMed ID: 21074337
[TBL] [Abstract][Full Text] [Related]
37. Chemical characterization and antifungal activity of
Vinciguerra V; Rojas F; Tedesco V; Giusiano G; Angiolella L
Nat Prod Res; 2019 Nov; 33(22):3273-3277. PubMed ID: 29726703
[TBL] [Abstract][Full Text] [Related]
38. The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles.
Iatta R; Puttilli MR; Immediato D; Otranto D; Cafarchia C
Mycoses; 2017 Mar; 60(3):178-182. PubMed ID: 27774659
[TBL] [Abstract][Full Text] [Related]
39. Agar Diffusion Procedures for Susceptibility Testing of Malassezia pachydermatis: Evaluation of Mueller-Hinton Agar Plus 2 % Glucose and 0.5 µg/ml Methylene Blue as the Test Medium.
Pasquetti M; Chiavassa E; Tizzani P; Danesi P; Peano A
Mycopathologia; 2015 Oct; 180(3-4):153-8. PubMed ID: 26138434
[TBL] [Abstract][Full Text] [Related]
40. Genotyping and antifungal susceptibility testing of multiple Malassezia pachydermatis isolates from otitis and dermatitis cases in pets: is it really worth the effort?
Álvarez-Pérez S; García ME; Peláez T; Blanco JL
Med Mycol; 2016 Jan; 54(1):72-79. PubMed ID: 26333353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
